SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease ...

Gossamer expects to initiate a global Phase 1b/2 clinical trial of GB5121 in PCNSL patients in the first half of 2022. Financial Results for Quarter and Full Year Ended December 31, 2021 Cash, Cash ...

Many animals in the midwater—the vast expanse of water between the surface and the deep seafloor—are always on the move. Unlike its bottom-dwelling kin, the gossamer worm (Tomopteris sp.) lives in ...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much ...

Investors in Gossamer Bio Inc (Symbol: GOSS) saw new options begin trading today, for the April 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Australian arachnids have carpeted the eastern Victoria countryside in gossamer silk after days of ...